Variable | Comparison | Data structure | Statistical test | Output | p value | Post hoc power | Effect size | |
---|---|---|---|---|---|---|---|---|
Number of USVs | a | Celf6-Extended, drug (FLX vs vehicle) | Non-normal | Two-way rmANOVA | F(1,197) = 80.854 | p < 0.000005 | 1 | 0.641 |
b | Celf6-Extended, age × drug × genotype interaction | Non-normal | Two-way rmANOVA | F(3.66,360.87) = 2.478 | p = 0.049 | 0.667 | 0.160 | |
c | Vehicle at P9 Celf6+/+ vs Celf6+/- vs Celf6-/- | Non-normal | Simple main effect | F(2,591) = 15.454 | p < 0.000005 | 0.967 | 0.422 | |
d | Celf6 +/+ at P5 FLX vs vehicle | Non-normal | Simple main effect | F(1,591) = 5.214 | p = 0.023 | 0.625 | 0.095 | |
d | Celf6 +/+ at P7 FLX vs vehicle | Non-normal | Simple main effect | F(1,591) = 24.168 | p < 0.000005 | 0.998 | 0.201 | |
d | Celf6 +/+ at P9 FLX vs vehicle | Non-normal | Simple main effect | F(1,591) = 32.669 | p < 0.000005 | 1 | 0.234 | |
d | Celf6 +/- at P5 FLX vs vehicle | Non-normal | Simple main effect | F(1,591) = 8.307 | p = 0.004 | 0.821 | 0.119 | |
d | Celf6 +/- at P7 FLX vs vehicle | Non-normal | Simple main effect | F(1,591) = 53.427 | p < 0.000005 | 1 | 0.301 | |
d | Celf6 +/- at P9 FLX vs vehicle | Non-normal | Simple main effect | F(1,591) = 35.638 | p < 0.000005 | 1 | 0.246 | |
d | Celf6 -/- at P5 FLX vs vehicle | Non-normal | Simple main effect | F(1,591) = 2.724 | p = 0.099 | 0.378 | 0.071 | |
d | Celf6 -/- at P7 FLX vs vehicle | Non-normal | Simple main effect | F(1,591) = 24.936 | p < 0.000005 | 0.999 | 0.204 | |
d | Celf6 -/- at P9 FLX vs vehicle | Non-normal | Simple main effect | F(1,591) = 1.380 | p = 0.241 | 0.217 | 0.045 | |
g | Long Prenatal, drug (FLX vs vehicle) | Non-normal | One-way rmANOVA | F(1,43) = 18.013 | p = 0.0001 | 0.986 | 0.647 | |
h | P5 FLX vs vehicle | Non-normal | Simple main effect | F(1,43) = 14.689 | p = 0.0004 | 0.963 | 0.585 | |
h | P7 FLX vs vehicle | Non-normal | Simple main effect | F(1,43) = 16.678 | p = 0.0002 | 0.979 | 0.622 | |
i | P9 FLX vs vehicle | Non-normal | Simple main effect | F(1,43) = 3.874 | p = 0.056 | 0.486 | 0.301 | |
k | Short Prenatal, drug (FLX vs vehicle) | Non-normal | One-way rmANOVA | F(1,43) = 0.041 | p = 0.840 | 0.052 | <0.000 | |
Average duration | e | Celf6-Extended, drug (FLX vs vehicle) | Normal | Linear mixed model | F(1,211.820) = 31.223 | p < 0.000005 | [0.005, 0.010] | |
Simple call pitch range | f | Celf6-Extended, drug (FLX vs vehicle) | Normal | Linear mixed model | F(1,170.380) = 38.155 | p < 0.000005 | [1895.15, 3675.32] | |
j | Long Prenatal, drug (FLX vs vehicle) | Normal | Linear mixed model | F(1,44.068) = 5.256 | p = 0.027 | [251.10, 3901.71] | ||
Weight | k | Celf6-Extended, age (P5 vs P7 vs P9 vs P14) | Normal | Two-way rmANOVA | F(1.46,286.7) = 2670.61 | p < 0.000005 | 1 | 3.673 |
m | Celf6-Extended, drug (FLX vs vehicle) | Normal | Two-way rmANOVA | F(1,197) = 56.921 | p < 0.000005 | 1 | 0.537 | |
n | Celf6 +/+ at P5 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 8.087 | p = 0.005 | 0.811 | 0.101 | |
n | Celf6 +/+ at P7 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 8.008 | p = 0.005 | 0.807 | 0.101 | |
n | Celf6 +/+ at P9 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 13.699 | p = 0.0003 | 0.959 | 0.132 | |
n | Celf6 +/+ at P14 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 34.952 | p < 0.000005 | 1 | 0.209 | |
n | Celf6 +/- at P5 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 14.860 | p = 0.0001 | 0.971 | 0.139 | |
n | Celf6 +/- at P7 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 18.036 | p = 0.00002 | 0.989 | 0.150 | |
n | Celf6 +/- at P9 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 21.454 | p < 0.000005 | 0.996 | 0.167 | |
n | Celf6 +/- at P14 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 42.427 | p < 0.000005 | 1 | 0.232 | |
n | Celf6 -/- at P5 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 7.462 | p = 0.006 | 0.779 | 0.095 | |
n | Celf6 -/- at P7 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 8.869 | p = 0.003 | 0.845 | 0.105 | |
n | Celf6 -/- at P9 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 12.822 | p = 0.0004 | 0.947 | 0.128 | |
n | Celf6 -/- at P14 FLX vs vehicle | Normal | Simple main effect | F(1,788) = 18.815 | p = 0.00002 | 0.991 | 0.153 | |
q | Celf6-Extended, litter (FLX vs vehicle) | Non-normal | Mann–Whitney U | U(203) = 4723.5 | p = 0.301 | N/A | 0.01 | |
k | Long Prenatal, age (P5 vs P7 vs P9 vs P14) | Normal | Two-way rmANOVA | F(2.26,97.31) = 1231.23 | p < 0.000005 | 1 | 5.330 | |
m | Long Prenatal, drug (FLX vs vehicle) | Normal | Two-way rmANOVA | F(1,43) = 20.887 | p = 0.00004 | 0.994 | 0.697 | |
n | P5 FLX vs vehicle | Normal | Simple main effect | F(1,172) = 4.163 | p = 0.043 | 0.528 | 0.157 | |
n | P7 FLX vs vehicle | Normal | Simple main effect | F(1,172) = 12.029 | p = 0.0007 | 0.932 | 0.264 | |
n | P9 FLX vs vehicle | Normal | Simple main effect | F(1,172) = 27.769 | p < 0.000005 | 0.999 | 0.402 | |
n | P14 FLX vs vehicle | Normal | Simple main effect | F(1,172) = 31.829 | p < 0.000005 | 1 | 0.430 | |
q | Long Prenatal, litter (FLX vs vehicle) | Non-normal | Mann–Whitney U | U(45) = 228 | p = 0.595 | N/A | 0.01 | |
k | Short Prenatal, age (P5 vs P7 vs P9 vs P14) | Normal | Two-way rmANOVA | F(1.64,70.58) = 892.959 | p < 0.000005 | 0.954 | 4.554 | |
o | Short Prenatal, drug (FLX vs vehicle) | Normal | Two-way rmANOVA | F(1,43) = 25.719 | p = 0.000008 | 0.999 | 0.773 | |
p | P5 FLX vs vehicle | Normal | Simple main effect | F(1,172) = 5.273 | p = 0.023 | 0.627 | 0.176 | |
p | P7 FLX vs vehicle | Normal | Simple main effect | F(1,172) = 13.753 | p = 0.0003 | 0.958 | 0.283 | |
p | P9 FLX vs vehicle | Normal | Simple main effect | F(1,172) = 19.138 | p = 0.00002 | 0.992 | 0.333 | |
p | P14 FLX vs vehicle | Normal | Simple main effect | F(1,172) = 49.019 | p < 0.000005 | 1 | 0.534 | |
r | Short Prenatal, litter (FLX vs vehicle) | Non-normal | Mann–Whitney U test | U(45) = 84.5 | p = 0.00003 | N/A | 0.35 | |
Latency to righting reflex | s | Celf6-Extended, drug (FLX vs vehicle) | Non-normal | Two-way ANOVA | F(1,191) = 13.753 | p = 0.004 | 0.827 | 0.212 |
t | Long Prenatal, drug (FLX vs vehicle) | Non-normal | Mann–Whitney U | U(45) = 223.0 | p = 0.545 | N/A | 0.01 | |
u | Short Prenatal, drug (FLX vs vehicle) | Non-normal | Mann–Whitney U | U(45) = 187.5 | p = 0.140 | N/A | 0.05 |
Effect size for F tests reported as Cohen’s f (Cohen, 1988; interpretation: 0.01 = small; 0.25 = medium; 0.40 = large) and for nonparametric tests reported as η2. 95% confidence intervals reported for linear mixed models.